United Therapeutics (UTHR) Inventory Average (2010 - 2026)

United Therapeutics has disclosed Inventory Average across 17 years of filings, most recently posting $180.7 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $180.7 million, up 11.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.7 million (up 11.78% YoY), and the FY2025 annual result was $170.5 million, up 26.44% from the prior year.
• Inventory Average came in at $180.7 million for Q1 2026 at United Therapeutics, up from $179.8 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $180.7 million in Q1 2026 to a low of $89.0 million in Q2 2022.
• The 5-year median for Inventory Average is $116.0 million (2024), against an average of $128.5 million.
• Across the five-year window, Inventory Average declined 3.05% in 2022 and jumped 40.95% in 2024, its largest moves.
• United Therapeutics' Inventory Average stood at $96.5 million in 2022, then grew by 11.97% to $108.0 million in 2023, then surged by 40.95% to $152.3 million in 2024, then increased by 18.06% to $179.8 million in 2025, then increased by 0.5% to $180.7 million in 2026.
• The last three Inventory Average figures came in at $180.7 million (Q1 2026), $179.8 million (Q4 2025), and $172.8 million (Q3 2025), per Business Quant data.